The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Left Ventricular Assist Devices Market Between 2026 And 2030?
The left ventricular assist devices market has observed substantial growth in recent years. Projections indicate it will grow from $1.73 billion in 2025 to $1.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This historic expansion can be linked to several factors, including the increasing occurrence of advanced heart failure, the restricted supply of donor hearts, the establishment of specialized cardiac care centers, advancements in surgical implantation methods, and the growing clinical acceptance of mechanical circulatory support.
The left ventricular assist devices market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach a valuation of $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. The expansion during the outlook period is primarily driven by factors such as an expanding elderly demographic experiencing cardiac issues, a heightened need for sustained heart failure management options, innovations in biocompatible substances, increasing incorporation of remote patient monitoring systems, and broader reimbursement availability for LVADs. Key developments anticipated in this period encompass a wider uptake of continuous flow LVADs, an increased application of LVADs for destination therapy, a heightened focus on compact implantable pump designs, an extension of remote patient monitoring features, and a stronger emphasis on the endurance and lifespan of these devices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12042&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Left Ventricular Assist Devices Market?
The increasing occurrence of cardiovascular diseases is projected to drive the expansion of the left ventricular assist device market in the future. Cardiovascular diseases are defined as a group of conditions impacting the heart and blood vessels. This category includes coronary heart disease, congenital heart disease, and various other ailments. In instances of advanced heart failure, a left ventricular assist device provides support to the heart’s left ventricle, which is responsible for pumping blood to the body’s tissues. For example, in January 2024, the American Heart Association, a US-based non-profit organization, stated that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking an increase of 4.0% from 224.4 per 100,000 in 2023. This demonstrates that the growing prevalence of cardiovascular diseases is fueling the growth of the left ventricular assist device market.
Which Market Segments Are Examined In The Left Ventricular Assist Devices Market Study?
The left ventricular assist devices market covered in this report is segmented –
1) By Type: Percutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
2) By Type Of Flow: Pulsatile, Non-Pulsatile
3) By Application: Bridge-To-Recovery (BTR) Therapy, Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy
4) By End-User: Cardiology Centers, Hospitals
Subsegments:
1) By Percutaneous Left Ventricular Assist Devices: Axial-Flow Percutaneous LVADs, Centrifugal-Flow Percutaneous LVADs
2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices, Pulsatile Flow Devices
Which Trends Are Influencing The Left Ventricular Assist Devices Market?
Leading companies in the left ventricular assist devices market are concentrating on developing advanced solutions, such as wave membrane technology, to supersede traditional rotary LVADs. A wave membrane solution refers to a next-generation heart pump designed to replicate physiological pulsatility and blood flow velocities akin to a healthy heart, potentially reducing complications associated with current devices. For instance, in September 2025, CorWave SA, a medical device company based in France, implanted its Left Ventricular Assisting System (LVAS) into a patient for the first time at St Vincent’s Hospital in Sydney. This innovation delivers full cardiac support, effectively unloading the left ventricle while maintaining an aortic pulse pressure of 25.5 ± 6.1 mmHg and consistent aortic valve opening. The device achieved primary study endpoints with no device-related adverse events at 30 days, and the patient successfully underwent heart transplantation after 84 days on support. CorWave’s LVAS represents a significant technological milestone in durable mechanical circulatory support by providing safe, physiological pulsatile flow that can improve patient outcomes and advance heart failure management.
Who Are The Primary Competitors In The Left Ventricular Assist Devices Market?
Major companies operating in the left ventricular assist devices market are Abbott Laboratories, Medtronic plc, Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc.
Read the full left ventricular assist devices market report here:
What Are The Leading Geographic Regions In The Left Ventricular Assist Devices Market?
North America was the largest region in the left ventricular assist devices market in 2025. The regions covered in the left ventricular assist devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Left Ventricular Assist Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12042&type=smp
Browse Through More Reports Similar to the Global Left Ventricular Assist Devices Market 2026, By The Business Research Company
Ventricular Assist Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
Cardiac Assist Devices And Equipment Market Report 2026
Heart Pump Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model